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17 ABSTRACT
18 Introduction: Weight management interventions in research studies and in clinical practice differ in 
19 length, advice, frequency of meetings, staff, and cost. Very few real-world programmes have 
20 published patient-related outcomes, and those that have published used different ways of reporting 
21 the information, making it impossible to compare interventions and further develop the evidence 
22 base. Developing a core outcome set for behavioural weight management programmes (BWMPs) for 
23 adults with overweight and obesity will allow different BWMPs to be compared and reveal which 
24 interventions work best for which members of the population. 
25 Methods and analysis: An expert group, comprised of 40 people who work in, refer to, or attend 
26 BWMPs for adults with overweight and obesity, will be asked to decide which outcomes services 
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27 should report. An online Delphi process will be employed to help the group reach consensus as to 
28 which outcomes should be measured and reported, and which definitions/instruments should be 
29 utilised in order to do so. The first stage of the Delphi process (3 rounds of questionnaires) will focus 
30 on outcomes while the second stage (3 additional rounds of questionnaires) will focus on 
31 definition/instrument selection.
32 Ethics and dissemination: Ethical approval for this study has been received from the University of 
33 Glasgow College of Medical, Veterinary and Life Sciences Ethics Committee. With regard to 
34 disseminating results, a report will be submitted to our funding body, the Chief Scientist Office of the 
35 Scottish Government Health Department. In addition, early findings will be shared with Public Health 
36 England (PHE) and Health Scotland, and results communicated via conference presentations, peer 
37 review publication and our institutions’ social media platforms.
38 Registration details: The project has been registered with the COMET (Core Outcome Measures in 
39 Effectiveness Trials) Initiative (http://www.comet-initiative.org/studies/details/1056).
40
41 STRENGTHS AND LIMITATIONS OF THIS STUDY
42  The major strength of this study is that it is the first of its kind and development of a core 
43 outcome set for BWMPs for adults with overweight and obesity is much needed in order to 
44 standardise reporting which, in turn, will lead to a better evidence base and improvements in 
45 weight management provision. 
46  It is a limitation that this study is wholly based in the United Kingdom (UK) as the results may 
47 need some adaptation to be suited to real-world programmes set within other healthcare 
48 systems. 
49  The recognised method for core outcome set development, the Delphi method, will be used 
50 to garner opinions from a wide range of individuals with expertise in behavioural weight 
51 management.
52  Review of all existing qualitative research studies will not be undertaken when generating the 
53 initial list of outcomes. However, qualitative work will be performed during core outcome set 
54 development as part of the Delphi process. 
55
56
57
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58
59 INTRODUCTION
60 Both the National Institute for Health and Care Excellence (NICE)1 and Scottish Intercollegiate 
61 Guidelines Network (SIGN)2 guidelines outline the intervention components to be included in a 
62 community weight management programme, namely calorie restriction, increased physical activity, 
63 and behavioural interventions. These have proven efficacy from randomised controlled trials3. 
64 However, their implementation in practice is inconsistent with mapping exercises in Scotland4 and 
65 England5 showing wide variation in services in terms of inclusion criteria, referral routes, delivery 
66 format, length and cost. Few real life services have published data and when they do publish, results 
67 can be poor with low levels of completion and ‘success’, and lack of longer term outcomes. 
68 The NICE guidance, ‘Weight management: lifestyle services for overweight or obese adults’1, identified 
69 a number of evidence gaps. These included, reliance on studies with short follow-up, collection of data 
70 at limited time points, small sample sizes, demographic samples that limit the ability to generalise, 
71 non-reporting of reasons for people dropping out and lack of evidence regarding the effect of 
72 population characteristics, such as  age, gender and socio economic status, on the effectiveness of a 
73 service. They noted a lack of comparisons between behavioural weight management programmes 
74 (BWMPs) in the United Kingdom (UK). This lack of an evidence base means that it is not possible to 
75 issue clear guidance as to which services are cost effective for which population groups.
76 Public Health England (PHE) has created a standard evaluation framework (SEF)6 to aid the evaluation 
77 of real world weight management programmes. However, in their 2015 weight management mapping 
78 exercise5, PHE reported that only 46% of adult weight management programmes use the SEF and, as 
79 it simply suggests areas for reporting and potential methods of analysis, there is a huge gap in 
80 standardised reporting. PHE had intended to analyse data from services but analysis was not possible 
81 due to the heterogeneity of reporting which included kilograms, % weight loss, average number of 
82 completers achieving 5% weight loss, body mass index (BMI) and more5. With regard to research 
83 studies, evidence suggests similar heterogeneity in terms of the reporting of outcomes7.
84 In an attempt to address this reporting issue, PHE issued a minimum dataset8 which provides an 
85 important core outcome recommendation for England, stipulating collection of certain demographics, 
86 service details, BMI and wellbeing at baseline, on completion of the programme and at 6 months and 
87 12 months post programme. A data collection tool provides information to support the 
88 standardisation of these data collection practices. This minimum dataset will be used to support PHE’s 
89 recently released document on adult tier 2 weight management service key performance indicators 
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90 (KPIs)9 which provides advice as to how weight status and service compliance should be reported and 
91 measured.
92 The study described herein has been funded through a Chief Scientist Office of the Scottish 
93 Government Health Department grant and will serve to further validate and build upon the PHE 
94 minimum dataset8 and KPI document9, while also informing a similar framework for Scotland. In 
95 addition, our research will provide much needed consensus on the measurements that should be 
96 used, such as questionnaires, something currently not covered in the PHE minimum dataset8 or KPI 
97 document9. Overall, this work will ensure more consistency in the measurement of the effectiveness 
98 of adult weight management services, leading to a better evidence base from which to identify which 
99 services are effective across a range of settings.
100 Recently, a core outcome set for bariatric and metabolic surgery was successfully developed using 
101 consensus methodology10. However, outcomes, including perioperative outcomes and post-operative 
102 complications, are not relevant for reporting from BWMPs. Therefore, the aim of this study, which will 
103 run from November 2017 until November 2018, is to gain expert consensus opinion on the core 
104 outcomes that should be reported from behavioural weight management interventions for adults with 
105 overweight and obesity in real world clinical practice as well as within research studies. 
106 The specific study objectives are to: 
107 1. Review the list of outcomes previously reported in the PHE SEF6, minimum dataset8 and KPI 
108 document9;
109 2. Identify additional outcomes reported in studies of structured, sustained, multi-component weight 
110 management programmes for adults from a systematic review of the literature; 
111 3. Select outcomes for inclusion in the core dataset using consensus methodology;
112 4. Select definitions/instruments for measuring chosen outcomes using consensus methodology.
113
114
115
116
117
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118 METHODS AND ANALYSIS
119 Identification of outcomes
120 We will generate a list of outcomes by review of the PHE SEF6, which was itself developed from a 
121 systematic review of the literature/focus groups, and from the PHE minimum dataset8 and KPI 
122 document9 which were developed through expert consensus and evidence from the peer review and 
123 grey literature.
124 Further outcomes will be selected by a review of included studies in the systematic review, ‘The clinical 
125 effectiveness of long-term weight management schemes for adults’ by Hartmann-Boyce et al. (2013)7, 
126 conducted during the development of NICE guidance1.  This systematic review7 assessed the effects 
127 of multicomponent BWMPs in overweight and adults with obesity which may be applicable in the UK. 
128 To be considered a multicomponent BWMP, the components of the programme had to include diet, 
129 physical activity and behavioural therapy (for example, counselling sessions). The scope included 
130 commercial weight loss programmes and non-commercial programmes, such as those delivered in 
131 primary care settings (for example, in GP practices)7.  It updated and expanded on an existing 
132 systematic review published in 2011 by Loveman et al.3 and used similar methods. The Loveman 
133 systematic review3 sought to assess the long-term clinical effectiveness and cost-effectiveness of 
134 multicomponent weight management schemes for adults in terms of weight loss and maintenance of 
135 weight loss.
136 Additional outcomes will be identified by updating the Hartmann-Boyce systematic review7, using 
137 the same inclusion criteria but extending search dates so that studies from 1/11/2012 until 30/09/17 
138 are included. Search and selection criteria for the systematic review are identical to those of 
139 Hartmann-Boyce7. With regard to database searches, Hartmann-Boyce7 searched BIOSIS, the 
140 Cochrane Database of Systematic Reviews, CENTRAL, the Conference Proceedings Citation Index, the 
141 Database of Abstracts of Reviews and Effects (DARE), Embase, the Health Technology Assessment 
142 database, Medline, PsychInfo, and Science Citation Index for references relating to weight loss 
143 programmes. They also screened references from three additional sources: reference lists in 
144 systematic reviews, documents received via the NICE call for evidence, and studies excluded from 
145 Loveman3 that they wished to re-examine.  Studies selected for inclusion had to be structured, 
146 sustained, multi-component adult weight management programmes with interventions which were 
147 a combination of diet and physical activity with a behaviour change strategy to influence lifestyle. In 
148 addition, programmes were required to include a follow-up of more than 12 months and be 
149 delivered in the health sector, in the community or commercially (i.e. applicable to the NHS).
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150 Two review authors will independently assess the abstracts of studies resulting from our literature 
151 search. Full text copies of studies appearing to meet the inclusion criteria will be further independently 
152 assessed by the 2 reviewers. Following discussion, agreement will be reached as to which studies to 
153 include. Any new outcomes will then be identified from the selected studies from both Hartmann-
154 Boyce7 and the updated review. 
155
156 Identification of Instruments
157 By review of the studies identified during the systematic reviews previously described, we will list 
158 instruments and definiti ns for selected outcomes. The study investigators will review this list and add 
159 any further suitable instruments.
160
161 Data Analysis and Presentation
162 For analysis purposes, the data will be tabulated so that the outcomes and instruments to be included 
163 in our Delphi are listed and the study/studies from which they were identified are displayed. Outcomes 
164 and instruments will be grouped under appropriate domains following review of selected outcomes.
165
166 Patient and Public Involvement
167 We will develop our core outcome set by means of consensus from an expert group. The sampling 
168 frame will aim to include members of the public with experience of NHS, local authority or commercial 
169 adult BWMPs in the UK, academics/policy makers/commissioners working in weight management, 
170 staff currently involved in delivering a BWMP for adults (without significant policy involvement), and 
171 primary care staff (referrers).  Consensus methodology will ensure that the opinions and preferences 
172 of members of the public will be given the same weighting as those of the other experts. 
173 There is no published agreement on the optimal size of an expert group; pragmatism is required while 
174 ensuring a range of opinions is garnered. Experience suggests a greater than 80% completion rate of 
175 Delphi questionnaires10;11. We will pre-approach potential volunteers to get agreement to participate 
176 from 10 members of the public, 20 academics/policy makers/commissioners, 20 weight management 
177 staff and 10 primary care staff. Forty experts will complete each of the two separate Delphi processes. 
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178 For the first Delphi process (stage 1, outcome selection), 10 members of the public, 10 
179 academics/policy makers/commissioners, 10 weight management staff and 10 primary care staff will 
180 be invited to participate. 
181 For the second Delphi (stage 2, instrument selection), 20 academics/policy makers/commissioners and 
182 20 weight management staff will be invited to participate with further members recruited if any of the 
183 original group (the 10 from each group who completed stage 1) have dropped out after the stage 1 
184 Delphi. The stage 2 Delphi will involve reading papers, looking at metrics and assessing validity of 
185 instruments/questionnaires. As in depth knowledge of academic literature and reporting tools is 
186 required, this stage of the Delphi process will be restricted to academics/policy 
187 makers/commissioners and weight management staff.
188 A small monetary incentive (a £35 gift voucher for either John Lewis or Amazon, depending on 
189 preference) will be offered to members of the public and primary care staff as this study is not of any 
190 direct benefit to them and could not be considered part of their role.
191 Staff working in weight management, academics/policy makers/commissioners and primary care staff 
192 will be recruited by email from the investigators and their personal contacts, and also via an email 
193 from the Association for the Study of Obesity. An information letter outlining the study will be 
194 attached to emails. On registering interest in our study, we will ask volunteers from these groups to 
195 provide us with information as to their role and geographical location within the UK.
196 Members of the public will be recruited by email from the Association for the Study of Obesity (which 
197 has lay members) and from professional contacts (a number of weight management programmes have 
198 lay members on steering committees). An information letter outlining the study will be attached to 
199 emails. (The information letter for the public will be written in lay language and will therefore differ 
200 slightly to the information letter for the other groups.) We have also registered with the NIHR People 
201 in Research website (https://www.peopleinresearch.org/) where our study will be advertised 
202 (following review to ensure suitability for a lay audience). Our information letter will be available to 
203 download from this website. On registering interest in our study, a ‘job description’ pro forma will be 
204 sent to members of the public via email. They will be asked to complete this pro forma and return it 
205 to us by email. The pro forma will provide us with information as to their gender, age, geographical 
206 location and experience of BWMPs.
207 In addition, Facebook and Twitter will be used to recruit members of the public, weight management 
208 staff, academics/policy makers/commissioners and primary care staff. Facebook posts and Tweets will 
209 link to a Mailchimp recruitment page where volunteers will be able to register their interest. On doing 
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210 so, they will receive the appropriate information letter. Weight management staff, academics/policy 
211 makers/commissioners and primary care staff will be asked to provide us with information as to their 
212 role and geographical location within the UK, and members of the public will be asked to complete 
213 the job description pro forma. 
214 Following provision of information regarding role and geographical location from weight management 
215 staff, academics/policy makers/commissioners and primary care staff, and the return of completed 
216 pro formas from members of the public, selection of volunteers to participate will commence. 
217 Selection will be based on our sampling framework which is outlined below. Volunteers will be sent 
218 an email to thank them for their interest and inform them if they have been selected to participate or 
219 not. A list of selected volunteers’ names and email addresses will then be sent to Clinvivo 
220 (www.clinvivo.com, a spin-out company of the University of Warwick) who will be conducting the 
221 Delphi process. Clinvivo will then contact these individuals by email, providing a link to the online 
222 Delphi questionnaire and instructions as to how to complete it.
223 On completion of the study, all participants (including members of the public) will be sent (by email) 
224 a copy of the final outcome and definition/instrument sets. In addition, where consent has been given, 
225 participants (including members of the public) will be named as contributors in the results publication.
226
227 Sampling Framework
228 To ensure our volunteers are a representative UK group, of the 20 weight management staff selected, 
229 at least 50% will be from England. Similarly, at least 50% of the 20 academic/policy 
230 maker/commissioner group will be from England. 8 of the 20 (40%) will be academics, 6 of the 20 
231 (30%) will be policy makers and 6 of the 20 (30%) will be commissioners. At least 50% of the 10 primary 
232 care staff selected will also be from England. With regard to members of the public, more than 50% 
233 will have experience of commercial BWMPs, more than 50% will be of working age, more than 30% 
234 will be male and less than 30% will be from any one region of the UK.
235
236 Delphi Survey
237 In order to develop our core outcome dataset, Delphi methodology will be used to gain consensus 
238 from our expert group. Two Delphis (stage 1 and stage 2) will be carried out using an online system 
239 developed and conducted by Clinvivo. Each Delphi will be carried out online over three sequential 
240 rounds with the same group of participants (Figure 1). For both stage 1 and stage 2 Delphis, only  those 
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241 who complete a questionnaire in round 1 will be eligible to participate in round 2, and only those who 
242 complete round 2 will be eligible to participate in round 3.
243 The stage 1 Delphi will involve asking each expert to score the importance of an outcome measure for 
244 use in weight management service outcome reporting. The scale will run from 1-9 with 1-3 indicating 
245 that the outcome is unimportant, 4-6 indicating that it is neither unimportant nor important and 7-9 
246 indicating that it is important. 
247 During the stage 2 Delphi, experts will be asked to score the appropriateness of outcome definitions 
248 and instruments for measurement of outcomes. Again, this will be done using a 1-9 scale with 1-3 
249 indicating that the definition/instrument is inappropriate, 4-6 indicating that it is neither appropriate 
250 nor inappropriate and 7-9 indicating that it is appropriate. 
251
252 Statistical Analysis
253 To assess disagreement and importance/appropriateness (and thus define consensus) the Research 
254 ANd Development (RAND)/ University of California Los Angeles (UCLA) appropriateness method will 
255 be used11. This involves calculating the median score, the inter-percentile range (IPR, 30th and 70th), 
256 and the inter-percentile range adjusted for symmetry (IPRAS), for each item being rated.
257 Fitch et al.11 first explored using the IPR alone in an attempt to develop a method that reproduced 
258 `classic' RAND definitions on panels that were multiples of 3 (which was typical in RAND's early 
259 consensus studies), but could also be extended to larger panel sizes. They found that in cases when 
260 agreement was good, the IPR should be narrow and in cases where there was disagreement, the IPR 
261 should be wide. However, an in-depth examination of the cases of disagreement identified by the IPR 
262 led to the discovery that when the ratings were symmetric, the IPR required to label an indication as 
263 disagreement was smaller than when the ratings were asymmetric, with respect to the middle. To 
264 overcome this, they developed the IPRAS which includes a correction factor for asymmetry (Equation 
265 1). 
266 Equation 1
267 IPRAS = IPRr + (AI x CFA)
268 Where IPRr is the inter-percentile range required for disagreement when perfect symmetry exists, AI is 
269 the asymmetry index, and CFA is the correction factor for asymmetry.
270
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271 The IPRAS is the threshold beyond which the IPR for a particular item indicates disagreement. Using 
272 the IPRAS and the IPR to judge disagreement reproduces ‘classic’ RAND definitions when applied to 
273 panels made up of multiples of 3, but can also be applied to panels of any size11. Variations on the 
274 stringencies of definitions of disagreement exist12 but similar examples of Delphi studies in health 
275 services research have used the classic definition13-18. In Equation 1, the optimal values for IPRr and 
276 CFA were derived following empirical work on a 9-point scale11. Fitch et al. found that using values of 
277 2.35 and 1.5 best reproduced the ‘classic’ definitions of agreement. These values will be used in this 
278 analysis. We will calculate AI as the distance between the central point of the IPR (p30+p70/2) and the 
279 central point of the scale (i.e. 5 on a 1-9 point scale.).
280 The IPRAS threshold is dependent on the symmetry of ratings about the median. Thus, each item 
281 requires a different IPRAS to be calculated. Consequently, the ith indication is rated with disagreement 
282 if the IPRi > IPRASi. In previous Delphi studies some have calculated the ratio of these: the 
283 disagreement index14;16;18. If the disagreement index was less than 1.0, it indicated there was no 
284 disagreement for the item in question. However, this is problematic in terms of interpretation because 
285 in the case that the IPR is zero, then the ratio is zero, which can cause confusion. For this reason we 
286 will present IPR and IPRAS values and simply comment on whether or not there is disagreement (i.e. 
287 when IPRi > IPRASi).
288 Judgement of appropriateness/importance also follows the classic RAND definitions, and this is 
289 assessed simply as whether the median rating falls between 1 to 3 (inappropriate/unimportant), 4 and 
290 6 (unsure), or 7 and 9 (appropriate/important).
291 At the end of each Delphi round, the median rating will be determined for individual 
292 outcomes/instruments and the distribution of ratings summarised in analysis conducted by Clinvivo 
293 and transferred to our research group (Figure 1).
294 During both stage 1 and stage 2, participants will be given 2 weeks to complete each round of the 
295 Delphi and will be reminded of the deadline for completion before starting the process. Participants 
296 will also be sent a reminder email 1 day before the deadline for each round.
297
298 Stage 1, Round 1 Delphi
299 The first Delphi study (stage 1) will be to select outcomes for inclusion in the core dataset. Full 
300 instructions will be provided to the expert group prior to completion of stage 1 questionnaires. 
301 Outcomes will be grouped under appropriate domains (broadly based on the PHE SEF6 and broadly 
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302 following the weight management chronological pathway) and full definitions of each domain and 
303 outcome will be provided in lay language. Participants will be asked to rate each outcome in turn using 
304 the 1-9 scale. During round 1, there will be an option for adding free text outlining reasons for any 
305 given rating and also for suggesting possible additional outcomes.
306
307 Analysis of Stage 1, Round 1
308 Additional outcomes listed by participants will be reviewed by two members of the study team (RMM 
309 and JL) to ensure they represent new outcomes. All outcomes, excluding any rated unimportant by 
310 consensus and including any new outcomes, will be carried forward to round 2.
311
312 Stage 1, Round 2 Delphi
313 In round 2, all experts will be asked to rate outcomes again. They will be shown their previous rating, 
314 the median expert group rating and any free text comments in the hope of ratings reaching a 
315 consensus. Experts will be asked to strongly consider the priority outcomes for weight management 
316 reporting in this round. Additional questions will be added as to the appropriate number of items to 
317 be included in the core outcome set.
318
319 Analysis of Stage 1, Round 2
320 All outcomes, excluding any rated unimportant by consensus and including any new outcomes, will be 
321 carried forward to round 3.
322
323 Stage 1, Round 3 Delphi
324 In round 3, all experts will be asked to rate outcomes for the final time. They will be shown their 
325 previous rating, the median expert group rating and any free text comments in the hope of ratings 
326 reaching a consensus. Should it be the case that a large number of outcomes are being rated as 
327 important at this stage, the need to decide which outcomes should take priority for weight 
328 management reporting will be reinforced to experts and they will be asked to rate only these priority 
329 outcomes as important. This will ensure development of a core outcome set of a manageable/practical 
330 size. 
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331 Analysis of Stage 1, Round 3
332 Using the consensus on the outcome set size and importance of outcomes, an outcome set will be 
333 developed by the study team using the results of the Delphi.
334
335 Stage 2, Round 1 Delphi
336 The second Delphi study (stage 2) will be for definition/instrument selection. Selection of instruments 
337 for inclusion in the stage 2 Delphi will be informed, as previously stated, by results/ratings/suggestions 
338 from stage 1, systematic review and input from co-investigators (LJE and SAS). 
339 Full instructions will be provided prior to completion of stage 2 questionnaires. As per stage 1, 
340 instruments will be grouped under appropriate domains and full definitions of each instrument will 
341 be provided. As stated, participants will be asked to rate each instrument in turn using a 1-9 scale of 
342 appropriateness (rather than importance). During the first round of the stage 2 instrument selection 
343 process , there will be an option for adding text outlining reasons for any given rating and also for 
344 suggesting possible additional instruments for measuring or defining outcomes.
345
346 Analysis of Stage 2, Round 1
347 Additional instruments listed by participants will be reviewed by two members of the study team 
348 (RMM and JL) to ensure they represent new instruments. All instruments, excluding those rated 
349 inappropriate by consensus and including any new instruments, will be carried forward to round 2.
350
351 Stage 2, Round 2 Delphi
352 In round 2, all experts will be asked to rate instruments again. They will be shown their previous rating, 
353 the median expert group rating and any free text comments in the hope of ratings reaching a 
354 consensus. Experts will be encouraged to rate instruments in a way that shows their preferences.
355
356 Analysis of Stage 2, Round 2
357 It may be that after round 2 an instrument set can be formed. Only those instruments related to an 
358 outcome for which there is no established consensus will be carried over to round 3.
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359 Stage 2, Round 3 Delphi
360 In round 3, all experts will be asked to select instruments for the final time. They will be shown their 
361 previous rating, the median expert group rating and any free text comments in the hope of ratings 
362 reaching a consensus.  In this round they will be asked to select the most appropriate instrument for 
363 each outcome in a binary format. 
364
365 Analysis of Stage 2, Round 3
366 A final instrument set matched to the core outcome set will be formed based on the consensus. In any 
367 areas where there is no consensus, the study team will adjudicate, taking account of free text 
368 comments. 
369
370 Data Storage
371 Participants’ contact details, including email addresses and telephone numbers, and the answers they 
372 provide, will only be stored by Clinvivo for the duration of the study. Clinvivo will not share 
373 participants’ contact details with any third parties and participants’ answers will be stored 
374 anonymously. Data will be encrypted before being stored on Clinvivo’s server and prior to being 
375 transferred to the University of Glasgow. On completion of the study, Clinvivo will destroy all data 
376 after transferring it to the University of Glasgow. The University will securely store the data on 
377 password access computers for a period of ten years following completion of the research project.
378
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386 Ethics 
387 Ethical approval for this study has been received from the University of Glasgow College of Medical, 
388 Veterinary and Life Sciences Ethics Committee. 
389
390 Dissemination
391 With regard to disseminating the results of our study, we will communicate our results via peer review 
392 publication, conference presentations, professional societies and also via our institution’s social media 
393 platforms. 
394 In addition, we will submit a report to our funding body, the Chief Scientist Office of the Scottish 
395 Government Health Department. We will also share early findings with PHE and Health Scotland. We 
396 will be in full discussion with both bodies to ensure that our work informs their evaluation plans for 
397 BWMPs for adults with overweight and obesity. 
398 Our study is, of course, restricted to the UK. This is due to BWMPs and their settings within health 
399 services being fairly country-specific. For example, in France and the Netherlands there is no health 
400 insurance funding of BWMPs and, in the USA, obesity services are tertiary, combining behavioural 
401 programmes with medication and bariatric surgery. In addition, instruments, such as language and 
402 health economic models, can be country-specific. Therefore, if used in an international context for 
403 trials or real world services, our core outcome and definition/instrument set may require further 
404 adaptation. 
405
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487 FIGURE LEGENDS
488 Figure 1. Schematic outlining the two stage Delphi study. In order to develop a core outcome set and 
489 definition/instrument set, Delphi methodology will be used to gain consensus from expert groups. 
490 Two Delphis (stage 1 and stage 2) will be carried out online over three rounds of questionnaires. The 
491 stage 1 Delphi will focus on development of a core outcome set. The stage 2 Delphi will focus on 
492 corresponding definition/instrument selection. PHE, Public Health England; SEF, standard evaluation 
493 framework; KPI, key performance indicator.
494
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Figure 1. Schematic outlining the two stage Delphi study. In order to develop a core outcome set and 
definition/instrument set, Delphi methodology will be used to gain consensus from expert groups. Two 
Delphis (stage 1 and stage 2) will be carried out online over three rounds of questionnaires. The stage 1 
Delphi will focus on development of a core outcome set. The stage 2 Delphi will focus on corresponding 
definition/instrument selection. PHE, Public Health England; SEF, standard evaluation framework; KPI, key 
performance indicator. 
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